# The innate immune system: A double-edged sword

**Authors:** Ditte S. Andersen, Julien Colombani

PMC · DOI: 10.1371/journal.pbio.3003088 · PLOS Biology · 2025-04-29

## TL;DR

The body's first line of defense can both fight and help cancer grow, as shown by new research on immune signaling and cancer genes.

## Contribution

Two studies reveal how cancer cells use innate immune signals to grow unchecked.

## Key findings

- Premalignant cells use Toll-NF-κB signaling to support tumor growth.
- This signaling works together with the Ras oncogene to enable uncontrolled cell growth.
- The findings highlight the dual role of the innate immune system in cancer.

## Abstract

Innate immunity serves as a crucial surveillance framework, but can be exploited to facilitate tumor progression. Two new PLOS Biology studies independently show how premalignant cells can exploit Toll-NF-κB signaling, in concert with oncogenic Ras, to enable unchecked growth

## Linked entities

- **Genes:** ras (resistance to audiogenic seizures) [NCBI Gene 19412]

## Full-text entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** tumor (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12040342/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12040342/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12040342/full.md

---
Source: https://tomesphere.com/paper/PMC12040342